The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Alan P. Johnson

Antibiotic Resistance Monitoring and Reference Laboratory

Central Public Health Laboratory

Colindale

London NW9 5HT

UK

[email]@phls.nhs.uk

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Antibiotic Resistance Monitoring and Reference Laboratory, Central Public Health Laboratory, Colindale, London NW9 5HT, UK. 2000 - 2002

References

  1. In vitro activity of cephalosporin RWJ-54428 (MC-02479) against multidrug-resistant gram-positive cocci. Johnson, A.P., Warner, M., Carter, M., Livermore, D.M. Antimicrob. Agents Chemother. (2002) [Pubmed]
  2. Activity of moxifloxacin against clinical isolates of Streptococcus pneumoniae from England and Wales. Johnson, A.P., Warner, M., George, R.C., Livermore, D.M. J. Antimicrob. Chemother. (2001) [Pubmed]
  3. Activity of moxifloxacin and other quinolones against pneumococci resistant to first-line agents, or with high-level ciprofloxacin resistance. Johnson, A.P., Warner, M., Livermore, D.M. Int. J. Antimicrob. Agents (2001) [Pubmed]
  4. Activity of the ketolide telithromycin (HMR-3647) against erythromycin-susceptible and -resistant pneumococci isolated in the UK. Johnson, A.P., Henwood, C.J., Tysall, L., Warner, M. Int. J. Antimicrob. Agents (2001) [Pubmed]
  5. Anti-MRSA cephalosporins Bristol-Myers Squibb. Johnson, A.P. Curr. Opin. Investig. Drugs (2001) [Pubmed]
  6. Telithromycin. Aventis Pharma. Johnson, A.P. Curr. Opin. Investig. Drugs (2001) [Pubmed]
  7. Antimicrobial susceptibility of Gram-positive bacteria: what's current, what's anticipated?. Johnson, A.P., Livermore, D.M., Tillotson, G.S. J. Hosp. Infect. (2001) [Pubmed]
  8. Activity of linezolid against multi-resistant gram-positive bacteria from diverse hospitals in the United Kingdom. Johnson, A.P., Warner, M., Livermore, D.M. J. Antimicrob. Chemother. (2000) [Pubmed]
  9. Susceptibility to quinupristin/dalfopristin and other antibiotics of vancomycin-resistant enterococci from the UK, 1997 to mid-1999. Johnson, A.P., Warner, M., Hallas, G., Livermore, D.M. J. Antimicrob. Chemother. (2000) [Pubmed]
  10. Pazufloxacin Toyama Chemical Co. Johnson, A.P. Curr. Opin. Investig. Drugs (2000) [Pubmed]
 
WikiGenes - Universities